Facial lipoatrophy may be one of the manifestations of HIV-associated lipodystrophy in patients treated with protease inhibitors. The authors are from the University of British Columbia in Vancouver.
Parameters:
(1) degree of atrophy of subcutaneous fat
(2) prominence of facial musculature
Atrophy of Subcutaneous Fat
Prominence of Facial Muscles
Grade
none
none
0
minimal to mild
none
1
moderate (deeper and longer central cheek atrophy)
zygomasticus major and other facial muscles beginning to show
2
marked but not widespread
clearly present but not widespread
3
marked and widespread, extending to the orbits, with no subcutaneous fat
clearly present over a wide area
4
To read more or access our algorithms and calculators, please log in or register.
